{
  "EnvironmentModule": {
    "MaterialResources": [
      "ATP/ADP/AMP",
      "NADH/NADPH/FADH2",
      "O2",
      "Water & Electrolytes",
      "Amino Acids, Glucose, Fatty Acids (Stock)"
    ],
    "Parameters": [
      "pH Value",
      "Temperature",
      "Blood Flow/Pressure",
      "Oxygen Partial Pressure",
      "Hormone & Metabolite Concentrations (e.g., Blood Glucose, Ammonia, Insulin, Glucagon)"
    ]
  },
  "FunctionalUnits": [
    {
      "UnitName": "1) Nutrient Metabolism",
      "Input": [
        "Glucose",
        "Fatty Acids",
        "Glycerol",
        "Amino Acids",
        "Lactate",
        "Ketone Bodies"
      ],
      "ControlLogic": [
        "([Glucose]blood > Threshold_high): Trigger Glycogenesis & Lipogenesis",
        "([Glucose]blood < Threshold_low): Trigger Glycogenolysis, beta-Oxidation, Gluconeogenesis",
        "ATP/AMP Ratio: High -> Synthesis/Storage; Low -> Energy Generation",
        "[Insulin]/[Glucagon] Ratio: High -> Anabolism; Low -> Catabolism"
      ],
      "Output": [
        "Glucose (to blood)",
        "Ketone Bodies",
        "VLDL (Fat transport)",
        "Albumin (Carrier)",
        "Hepatic Glycogen (Internal Storage)"
      ]
    },
    {
      "UnitName": "2) Detoxification",
      "Input": [
        "Xenobiotics (Drugs, Alcohol, Toxins)",
        "Endogenous Toxic Products (Bilirubin, Steroid Metabolites)"
      ],
      "ControlLogic": [
        "([Toxin]in > 0): Activate Cytochrome P450 (Phase I Oxidation/Reduction)",
        "Phase I Product Polarity Insufficient: Trigger Phase II Conjugation (Glucuronidation, Sulfation, etc.)",
        "Biliary Pathway Patent: Trigger Excretion via Bile"
      ],
      "Output": [
        "Water-soluble, Non-toxic Metabolites (via Blood or Bile)"
      ]
    },
    {
      "UnitName": "3) Secretion and Synthesis",
      "Input": [
        "Amino Acids",
        "Fatty Acids",
        "Cholesterol",
        "Water & Electrolytes"
      ],
      "ControlLogic": [
        "Osmotic Pressure/Plasma Protein Level Low: Trigger Albumin Synthesis",
        "Coagulation Cascade Activated: Trigger Clotting Factor Synthesis (Prothrombin, VII, IX, X)",
        "Cholesterol Surplus: Trigger Bile Acid and Bile Salt Synthesis",
        "Specific Hormone Signals (e.g., Estrogen): Trigger Carrier Protein Synthesis"
      ],
      "Output": [
        "Plasma Proteins (Albumin, Globulins)",
        "Clotting Factors",
        "Bile (Bile Salts, Cholesterol, Bilirubin)"
      ]
    },
    {
      "UnitName": "4) Nitrogen Processing and Urea Cycle",
      "Input": [
        "Ammonia (from Amino Acid Degradation, Gut Bacteria)",
        "Amino Acid Carbon Skeletons"
      ],
      "ControlLogic": [
        "([Ammonia]blood > Threshold_toxic): Activate Urea Cycle to form non-toxic Urea",
        "ATP Supply Adequate: Urea Cycle is ATP-dependent",
        "Amino Acid Catabolism Active: Provide NH3 and Aspartate"
      ],
      "Output": [
        "Urea (to Kidney for excretion)",
        "Glucose (from Gluconeogenesis)",
        "Ketone Bodies or Fatty Acids"
      ]
    },
    {
      "UnitName": "5) Hormone-Neuro-Immune Signaling Regulation",
      "Input": [
        "Insulin",
        "Glucagon",
        "Epinephrine",
        "Thyroid Hormone",
        "Cortisol",
        "Cytokines (e.g., IL-6)",
        "Nerve Signals (e.g., Vagus Nerve)"
      ],
      "ControlLogic": [
        "Endocrine Receptor Activation: Regulate downstream metabolic pathways",
        "Inflammatory Signal Activation (Cytokine Increase): Trigger Acute Phase Protein Synthesis (CRP, SAA)",
        "Nerve Signal (e.g., Sympathetic Excitation): Trigger Short-term Glycogenolysis"
      ],
      "Output": [
        "Cytokine Receptor Signal Transduction Products (Internal effect)",
        "Acute Phase Proteins (Secreted to Blood)",
        "Hormone-Binding Proteins"
      ]
    }
  ]
}